We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02111031
Recruitment Status : Withdrawn (The company decided not to start the study.)
First Posted : April 10, 2014
Last Update Posted : June 19, 2015
The Cleveland Clinic
Information provided by (Responsible Party):
Janssen Diagnostics, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : May 2017
  Estimated Study Completion Date : May 2017